Variant report

Variant	nsv873814
Chromosome Location	chr2:34591020-34703057
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF2	chr2:34590863-34591498	H1-hESC	embryonic stem cell:	n/a	n/a
2	BATF	chr2:34626250-34626627	GM12878	blood:	n/a	chr2:34626402-34626412 chr2:34626401-34626412
3	BATF	chr2:34626271-34626588	GM12878	blood:	n/a	chr2:34626402-34626412 chr2:34626401-34626412
4	BCL11A	chr2:34591088-34591422	H1-hESC	embryonic stem cell:	n/a	n/a
5	BCL11A	chr2:34626351-34626529	GM12878	blood:	n/a	chr2:34626400-34626409 chr2:34626401-34626410
6	BCL3	chr2:34633212-34633509	GM12878	blood:	n/a	chr2:34633318-34633327 chr2:34633317-34633326
7	BCL3	chr2:34633202-34633571	GM12878	blood:	n/a	chr2:34633318-34633327 chr2:34633317-34633326
8	BHLHE40	chr2:34633159-34633448	GM12878	blood:	n/a	n/a
9	CCNT2	chr2:34623370-34623530	K562	blood:	n/a	n/a
10	CEBPB	chr2:34637610-34637983	IMR90	lung:	n/a	chr2:34637786-34637795 chr2:34637786-34637795 chr2:34637786-34637795 chr2:34637784-34637797 chr2:34637785-34637796 chr2:34637786-34637795
11	CEBPB	chr2:34610798-34611191	HepG2	liver:	n/a	chr2:34610999-34611008 chr2:34611030-34611038 chr2:34610997-34611010 chr2:34610999-34611008 chr2:34610999-34611008 chr2:34610997-34611010 chr2:34610999-34611008 chr2:34610997-34611008 chr2:34610997-34611010 chr2:34610998-34611009 chr2:34610997-34611008
12	CEBPB	chr2:34608697-34608972	HepG2	liver:	n/a	n/a
13	CEBPB	chr2:34651784-34652054	A549	lung:	n/a	chr2:34651953-34651964
14	CEBPB	chr2:34633823-34633989	A549	lung:	n/a	chr2:34633880-34633891 chr2:34633878-34633891 chr2:34633878-34633889 chr2:34633878-34633891
15	CEBPB	chr2:34637625-34637979	A549	lung:	n/a	chr2:34637786-34637795 chr2:34637786-34637795 chr2:34637786-34637795 chr2:34637784-34637797 chr2:34637785-34637796 chr2:34637786-34637795
16	CEBPB	chr2:34633778-34633979	HepG2	liver:	n/a	chr2:34633880-34633891 chr2:34633878-34633891 chr2:34633878-34633889 chr2:34633878-34633891
17	CEBPB	chr2:34637705-34637966	MCF-7	breast:	n/a	chr2:34637786-34637795 chr2:34637786-34637795 chr2:34637786-34637795 chr2:34637784-34637797 chr2:34637785-34637796 chr2:34637786-34637795
18	CEBPB	chr2:34637621-34637979	H1-hESC	embryonic stem cell:	n/a	chr2:34637786-34637795 chr2:34637786-34637795 chr2:34637786-34637795 chr2:34637784-34637797 chr2:34637785-34637796 chr2:34637786-34637795
19	CEBPB	chr2:34651815-34652025	H1-hESC	embryonic stem cell:	n/a	chr2:34651953-34651964
20	CEBPB	chr2:34590884-34591363	H1-hESC	embryonic stem cell:	n/a	n/a
21	CEBPB	chr2:34637613-34637978	K562	blood:	n/a	chr2:34637786-34637795 chr2:34637786-34637795 chr2:34637786-34637795 chr2:34637784-34637797 chr2:34637785-34637796 chr2:34637786-34637795
22	CEBPB	chr2:34637607-34637980	HepG2	liver:	n/a	chr2:34637786-34637795 chr2:34637786-34637795 chr2:34637786-34637795 chr2:34637784-34637797 chr2:34637785-34637796 chr2:34637786-34637795
23	CEBPB	chr2:34651788-34652080	HepG2	liver:	n/a	chr2:34651953-34651964
24	CEBPB	chr2:34651786-34652048	K562	blood:	n/a	chr2:34651953-34651964
25	CEBPB	chr2:34651781-34652060	IMR90	lung:	n/a	chr2:34651953-34651964
26	CEBPB	chr2:34610824-34611131	Hela-S3	cervix:	n/a	chr2:34610999-34611008 chr2:34611030-34611038 chr2:34610997-34611010 chr2:34610999-34611008 chr2:34610999-34611008 chr2:34610997-34611010 chr2:34610999-34611008 chr2:34610997-34611008 chr2:34610997-34611010 chr2:34610998-34611009 chr2:34610997-34611008
27	CEBPB	chr2:34637712-34637983	ECC-1	luminal epithelium:	n/a	chr2:34637786-34637795 chr2:34637786-34637795 chr2:34637786-34637795 chr2:34637784-34637797 chr2:34637785-34637796 chr2:34637786-34637795
28	CEBPB	chr2:34610850-34611138	MCF-7	breast:	n/a	chr2:34610999-34611008 chr2:34611030-34611038 chr2:34610997-34611010 chr2:34610999-34611008 chr2:34610999-34611008 chr2:34610997-34611010 chr2:34610999-34611008 chr2:34610997-34611008 chr2:34610997-34611010 chr2:34610998-34611009 chr2:34610997-34611008
29	CEBPB	chr2:34661633-34661923	HepG2	liver:	n/a	chr2:34661857-34661869
30	CEBPB	chr2:34637703-34637950	MCF-7	breast:	n/a	chr2:34637786-34637795 chr2:34637786-34637795 chr2:34637786-34637795 chr2:34637784-34637797 chr2:34637785-34637796 chr2:34637786-34637795
31	CEBPB	chr2:34637693-34638019	A549	lung:	n/a	chr2:34637786-34637795 chr2:34637786-34637795 chr2:34637786-34637795 chr2:34637784-34637797 chr2:34637785-34637796 chr2:34637786-34637795
32	CEBPB	chr2:34637636-34637968	Hela-S3	cervix:	n/a	chr2:34637786-34637795 chr2:34637786-34637795 chr2:34637786-34637795 chr2:34637784-34637797 chr2:34637785-34637796 chr2:34637786-34637795
33	CEBPB	chr2:34610815-34611181	A549	lung:	n/a	chr2:34610999-34611008 chr2:34611030-34611038 chr2:34610997-34611010 chr2:34610999-34611008 chr2:34610999-34611008 chr2:34610997-34611010 chr2:34610999-34611008 chr2:34610997-34611008 chr2:34610997-34611010 chr2:34610998-34611009 chr2:34610997-34611008
34	CEBPB	chr2:34610823-34611180	IMR90	lung:	n/a	chr2:34610999-34611008 chr2:34611030-34611038 chr2:34610997-34611010 chr2:34610999-34611008 chr2:34610999-34611008 chr2:34610997-34611010 chr2:34610999-34611008 chr2:34610997-34611008 chr2:34610997-34611010 chr2:34610998-34611009 chr2:34610997-34611008
35	CEBPB	chr2:34634613-34634777	A549	lung:	n/a	n/a
36	CHD2	chr2:34590960-34591415	H1-hESC	embryonic stem cell:	n/a	n/a
37	CHD2	chr2:34672099-34672569	H1-hESC	embryonic stem cell:	n/a	n/a
38	CHD2	chr2:34632765-34632782	GM12878	blood:	n/a	n/a
39	CTCF	chr2:34644200-34644350	GM12864	blood:	n/a	n/a
40	CTCF	chr2:34591200-34591350	HAc	cerebellar:	n/a	chr2:34591235-34591243
41	CTCF	chr2:34591202-34591372	Medullo	brain:	n/a	chr2:34591235-34591243
42	CTCF	chr2:34591180-34591330	WERI-Rb-1	eye:	n/a	chr2:34591235-34591243
43	CTCF	chr2:34685880-34686030	HEK293	kidney:	n/a	n/a
44	CTCF	chr2:34591200-34591350	HEK293	kidney:	n/a	chr2:34591235-34591243
45	CTCF	chr2:34591140-34591290	RPTEC	kidney:	n/a	chr2:34591235-34591243
46	CTCF	chr2:34591220-34591370	RPTEC	kidney:	n/a	chr2:34591235-34591243
47	CTCF	chr2:34591160-34591310	HRPEpiC	eye:	n/a	chr2:34591235-34591243
48	CTCF	chr2:34591160-34591310	HRE	kidney:	n/a	chr2:34591235-34591243
49	CTCF	chr2:34591200-34591350	WERI-Rb-1	eye:	n/a	chr2:34591235-34591243
50	CTCF	chr2:34600840-34600990	GM12874	blood:	n/a	n/a

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr2:34633637-34633687	GM12878	blood:	n/a
2	chr2:34633637-34633687	GM06990	blood:	n/a
3	chr2:34633637-34633687	HPAEpiC	pulmonary alveolar:	n/a
4	chr2:34633637-34633687	SAEC	small airway:	n/a
5	chr2:34633637-34633687	RPTEC	kidney:	n/a
6	chr2:34633637-34633687	U87	brain:	n/a
7	chr2:34633637-34633687	SKMC	muscle:	n/a
8	chr2:34633637-34633687	GM12892	blood:	n/a
9	chr2:34633637-34633687	HRPEpiC	eye:	n/a
10	chr2:34633637-34633687	HMEC	breast:	n/a
11	chr2:34633637-34633687	Caco-2	colon:	n/a
12	chr2:34633637-34633687	GM12891	blood:	n/a
13	chr2:34633637-34633687	AG09309	skin:	n/a
14	chr2:34633637-34633687	HRE	kidney:	n/a
15	chr2:34633637-34633687	MCF10A-Er-Src	breast:	n/a
16	chr2:34633637-34633687	PFSK-1	brain:	n/a
17	chr2:34633637-34633687	AoSMC	blood vessel:	n/a
18	chr2:34633637-34633687	SK-N-SH_RA	brain:	n/a
19	chr2:34633637-34633687	HCF	heart:	n/a
20	chr2:34633637-34633687	NHBE	bronchial:	n/a
21	chr2:34633637-34633687	HIPEpiC	eye:	n/a
22	chr2:34633637-34633687	BE2_C	brain:	n/a
23	chr2:34633637-34633687	LNCaP	prostate:	n/a
24	chr2:34633637-34633687	NT2-D1	testis:	n/a
25	chr2:34633637-34633687	ProgFib	skin:	n/a
26	chr2:34633637-34633687	Hela-S3	cervix:	n/a
27	chr2:34633637-34633687	AG09319	gingival:	n/a
28	chr2:34633637-34633687	HEK293	kidney:	embryo
29	chr2:34633637-34633687	H1-hESC	embryonic stem cell:	embryo
30	chr2:34633637-34633687	HRCEpiC	kidney:	n/a
31	chr2:34633637-34633687	PANC-1	pancreas:	n/a
32	chr2:34633637-34633687	IMR90	lung:	fetal
33	chr2:34633637-34633687	HAEpiC	amniotic membrane:	n/a
34	chr2:34633637-34633687	HUVEC	blood vessel:	n/a
35	chr2:34633637-34633687	BJ	skin:	n/a
36	chr2:34633637-34633687	PrEC	prostate:	n/a
37	chr2:34633637-34633687	SK-N-SH	brain:	n/a
38	chr2:34633637-34633687	NB4	blood:	n/a
39	chr2:34633637-34633687	HCT-116	colon:	n/a
40	chr2:34633637-34633687	ECC-1	luminal epithelium:	n/a
41	chr2:34633637-34633687	Jurkat	blood:	n/a
42	chr2:34633637-34633687	CMK	blood:	n/a
43	chr2:34633637-34633687	HNPCEpiC	eye:	n/a
44	chr2:34633637-34633687	NHDF-neo	bronchial:	n/a
45	chr2:34633637-34633687	HCPEpiC	choroid plexus:	n/a
46	chr2:34633637-34633687	AG04449	skin:	fetal
47	chr2:34633637-34633687	HCM	heart:	n/a
48	chr2:34633637-34633687	GM19239	blood:	n/a
49	chr2:34633637-34633687	MCF-7	breast:	n/a
50	chr2:34633637-34633687	A549	lung:	n/a

No.	Distal block	Cell Line	Cell type
1	chr2:34624209..34626557-chr2:34688886..34690644,2	K562	blood:
2	chr2:34636657..34638446-chr2:34644514..34646250,2	K562	blood:
3	chr17:57969237..57970939-chr2:34675539..34678526,2	MCF-7	breast:
4	chr2:34636657..34638446-chr2:34644514..34646250,2	K562	blood:
5	chr17:41466170..41467868-chr2:34623111..34624611,2	MCF-7	breast:
6	chr12:46765173..46767943-chr2:34590937..34593382,2	MCF-7	breast:
7	chr2:34590795..34592507-chr2:34600278..34603033,2	K562	blood:
8	chr2:34590795..34592507-chr2:34600278..34603033,2	K562	blood:
9	chr2:34624209..34626557-chr2:34688886..34690644,2	K562	blood:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-RASGRP3-3	chr2:34609584-34609796	NONHSAT070034
2	lnc-RASGRP3-3	chr2:34609584-34609636	ENSG00000226785
3	lnc-RASGRP3-3	chr2:34608855-34609276	ENSG00000226785

Variant related genes	Relation type
ENSG00000212025	TF binding region
ENSG00000226785	TF binding region
ENSG00000212025	CpG island
ENSG00000226785	CpG island
ENSG00000108423	chromatin interactions
ENSG00000134294	chromatin interactions
ENSG00000108443	chromatin interactions
ENSG00000188825	chromatin interactions
ENSG00000258096	chromatin interactions

Extended variants
information (count: 2287 )
Associated
traits (count: 65 )

Variant overlapped rSNPs/rCNVs (count:2287 , 50 per page) page: 1 2 3 4 5 6 7 ... 46

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs13005071	chr2:34591020-34591021	Enhancers Weak transcription Flanking Active TSS Active TSS	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs193281166	chr2:34591023-34591024	Enhancers Weak transcription Flanking Active TSS Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
3	rs537011313	chr2:34591030-34591031	Enhancers Weak transcription Flanking Active TSS Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
4	rs557367962	chr2:34591066-34591067	Enhancers Weak transcription Flanking Active TSS Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
5	rs577413103	chr2:34591070-34591071	Enhancers Weak transcription Flanking Active TSS Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
6	rs548291495	chr2:34591085-34591086	Enhancers Weak transcription Flanking Active TSS Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
7	rs559659548	chr2:34591086-34591087	Enhancers Weak transcription Flanking Active TSS Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
8	rs553187664	chr2:34591129-34591130	Enhancers Weak transcription Flanking Active TSS Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
9	rs140563906	chr2:34591153-34591154	Enhancers Weak transcription Flanking Active TSS Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
10	rs573039585	chr2:34591225-34591226	Enhancers Active TSS Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
11	rs184851217	chr2:34591239-34591240	Enhancers Active TSS Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
12	rs372891797	chr2:34591241-34591242	Enhancers Active TSS Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
13	rs530030435	chr2:34591259-34591260	Enhancers Active TSS Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
14	rs575502744	chr2:34591260-34591261	Enhancers Active TSS Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
15	rs543853512	chr2:34591267-34591268	Enhancers Active TSS Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
16	rs563782678	chr2:34591301-34591302	Enhancers Active TSS Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
17	rs201813610	chr2:34591310-34591311	Enhancers Active TSS Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
18	rs532838810	chr2:34591330-34591331	Enhancers Active TSS Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
19	rs369711896	chr2:34591332-34591333	Enhancers Active TSS Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
20	rs559841087	chr2:34591345-34591346	Enhancers Active TSS Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
21	rs528632921	chr2:34591398-34591399	Enhancers Active TSS Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
22	rs548775280	chr2:34591406-34591407	Enhancers Active TSS Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
23	rs13010930	chr2:34591417-34591418	Enhancers Active TSS Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
24	rs189325182	chr2:34591420-34591421	Enhancers Active TSS Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
25	rs180946299	chr2:34591425-34591426	Enhancers Active TSS Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
26	rs570893721	chr2:34591430-34591431	Enhancers Active TSS Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
27	rs370785389	chr2:34591434-34591435	Enhancers Active TSS Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
28	rs146948950	chr2:34591447-34591448	Enhancers Active TSS Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
29	rs13010764	chr2:34591497-34591498	Enhancers Active TSS Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
30	rs80348111	chr2:34591522-34591523	Enhancers Active TSS Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
31	rs535252235	chr2:34591564-34591565	Enhancers Active TSS Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
32	rs534906734	chr2:34591566-34591567	Enhancers Active TSS Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
33	rs185118413	chr2:34591576-34591577	Enhancers Active TSS Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
34	rs17015189	chr2:34591607-34591608	Enhancers Active TSS Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
35	rs6735602	chr2:34591673-34591674	Enhancers Active TSS Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
36	rs557648949	chr2:34591689-34591690	Enhancers Active TSS Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
37	rs535583788	chr2:34591698-34591699	Enhancers Active TSS Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
38	rs577192054	chr2:34591717-34591718	Enhancers Active TSS Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
39	rs56775378	chr2:34591719-34591720	Enhancers Active TSS Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
40	rs397729056	chr2:34591728-34591729	Enhancers Active TSS Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
41	rs116182642	chr2:34591802-34591803	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
42	rs13011808	chr2:34591816-34591817	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
43	rs542055194	chr2:34591842-34591843	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
44	rs6735952	chr2:34591848-34591849	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
45	rs116611697	chr2:34591861-34591862	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
46	rs76708316	chr2:34591878-34591879	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
47	rs138023208	chr2:34591905-34591906	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
48	rs143370436	chr2:34591930-34591931	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
49	rs547026258	chr2:34591955-34591956	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
50	rs189874464	chr2:34591974-34591975	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:65)

Disease	PMID	Source
Breast cancer	17393978	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Breast cancer	17603634	CNVD
Medulloblastoma	21979893	CNVD
Lynch syndrome	18415027	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Ovarian neoplasms	16753589	CNVD
Glioblastoma multiforme	17387387	CNVD
Neuroblastoma	17533364	CNVD
Neuroblastoma	18923191	CNVD
Endometrial cancer	22040021	CNVD
Adrenal tumor	17535989	CNVD
Breast cancer	21264507	CNVD
Basal cell lymphoma	17053054	CNVD
Medulloblastoma	17522785	CNVD
Cancer	23418310	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Ependymoma	16718352	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
lymphocytic leukemia	21291569	CNVD
Prostate cancer	18632612	CNVD
Bladder cancer	21909424	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Intellectual disability	22102821	CNVD
Cancer	20164919	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Autism	22495311	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Follicular lymphoma	20505157	CNVD
Autism	17483303	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Esophageal adenocarcinoma	18519675	CNVD
Medulloblastoma	20607354	CNVD
Leukemia	18628472	CNVD
Autism	19521722	CNVD
Autism	18522746	CNVD
Breast cancer	21364760	CNVD
Wilms tumour	21544195	CNVD
Non-small cell lung cancer	18927303	CNVD
Hereditary gingival fibromatosis	19633868	CNVD
Breast cancer	21785460	CNVD
Lung cancer	18438408	CNVD
Myelofibrosis	22110671	CNVD
Breast cancer	21045282	CNVD
Prostate cancer	21965145	CNVD
Breast cancer	16397240	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Neuroblastoma	21508638	CNVD
Neurodevelopmental disorder	22521361	CNVD
Neurocytoma	17123091	CNVD
Autism	22495309	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
Glioma	20126413	CNVD
early-passage human iPS cells	21368824	CNVD
small cell lung cancer	20016488	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD

Chromatin state (count:143 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr2:34587400-34591400	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
2	chr2:34589000-34592400	Enhancers	ES-I3 Cell Line	embryonic stem cell
3	chr2:34589200-34591200	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
4	chr2:34590000-34592600	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
5	chr2:34590200-34591400	Weak transcription	H1 Cell Line	embryonic stem cell
6	chr2:34590400-34592200	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
7	chr2:34590800-34591200	Enhancers	ES-WA7 Cell Line	embryonic stem cell
8	chr2:34590800-34591200	Enhancers	Fetal Intestine Small	intestine
9	chr2:34590800-34591400	Enhancers	Fetal Adrenal Gland	Adrenal Gland
10	chr2:34590800-34591600	Flanking Active TSS	HUES48 Cell Line	embryonic stem cell
11	chr2:34590800-34591600	Flanking Active TSS	HUES6 Cell Line	embryonic stem cell
12	chr2:34590800-34591800	Flanking Active TSS	HUES64 Cell Line	embryonic stem cell
13	chr2:34590800-34592000	Flanking Active TSS	iPS-18 Cell Line	embryonic stem cell
14	chr2:34590800-34592200	Enhancers	Fetal Kidney	kidney
15	chr2:34591000-34591200	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
16	chr2:34591000-34591200	Flanking Active TSS	iPS-20b Cell Line	embryonic stem cell
17	chr2:34591000-34591400	Active TSS	iPS-15b Cell Line	embryonic stem cell
18	chr2:34591000-34591400	Enhancers	Cortex derived primary cultured neurospheres	brain
19	chr2:34591000-34591400	Enhancers	Fetal Intestine Large	intestine
20	chr2:34591000-34591600	Enhancers	Fetal Brain Female	brain
21	chr2:34591000-34591600	Enhancers	Fetal Stomach	stomach
22	chr2:34591000-34592000	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
23	chr2:34591000-34592000	Enhancers	Fetal Lung	lung
24	chr2:34591000-34593400	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
25	chr2:34591200-34591400	Active TSS	iPS-20b Cell Line	embryonic stem cell
26	chr2:34591200-34591600	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
27	chr2:34591200-34591600	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
28	chr2:34591200-34591800	Active TSS	ES-WA7 Cell Line	embryonic stem cell
29	chr2:34591400-34591600	Flanking Active TSS	iPS-15b Cell Line	embryonic stem cell
30	chr2:34591400-34592200	Flanking Active TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
31	chr2:34591400-34592200	Flanking Active TSS	iPS-20b Cell Line	embryonic stem cell
32	chr2:34591400-34592400	Enhancers	H1 Cell Line	embryonic stem cell
33	chr2:34591600-34592200	Enhancers	HUES6 Cell Line	embryonic stem cell
34	chr2:34591600-34592200	Enhancers	iPS-15b Cell Line	embryonic stem cell
35	chr2:34591600-34592400	Enhancers	HUES48 Cell Line	embryonic stem cell
36	chr2:34591600-34592400	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
37	chr2:34591800-34592000	Enhancers	ES-WA7 Cell Line	embryonic stem cell
38	chr2:34591800-34593000	Enhancers	HUES64 Cell Line	embryonic stem cell
39	chr2:34592000-34592200	Enhancers	iPS-18 Cell Line	embryonic stem cell
40	chr2:34592200-34592600	Enhancers	iPS-20b Cell Line	embryonic stem cell
41	chr2:34592200-34593000	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
42	chr2:34592200-34593200	Weak transcription	HUES6 Cell Line	embryonic stem cell
43	chr2:34592200-34593200	Weak transcription	iPS-15b Cell Line	embryonic stem cell
44	chr2:34592400-34593400	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
45	chr2:34592400-34599000	Weak transcription	H1 Cell Line	embryonic stem cell
46	chr2:34592400-34599000	Weak transcription	HUES48 Cell Line	embryonic stem cell
47	chr2:34592600-34593200	Weak transcription	iPS-20b Cell Line	embryonic stem cell
48	chr2:34593000-34598400	Weak transcription	HUES64 Cell Line	embryonic stem cell
49	chr2:34593200-34593400	Enhancers	iPS-15b Cell Line	embryonic stem cell
50	chr2:34593200-34593400	Enhancers	iPS-20b Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links